Advances in HIV-1 Vaccine Development

Yong Gao, Paul F McKay, Jamie F S Mann

Research output: Contribution to journalReview article (Academic Journal)peer-review

50 Citations (Scopus)


An efficacious HIV-1 vaccine is regarded as the best way to halt the ongoing HIV-1 epidemic. However, despite significant efforts to develop a safe and effective vaccine, the modestly protective RV144 trial remains the only efficacy trial to provide some level of protection against HIV-1 acquisition. This review will outline the history of HIV vaccine development, novel technologies being applied to HIV vaccinology and immunogen design, as well as the studies that are ongoing to advance our understanding of vaccine-induced immune correlates of protection.

Original languageEnglish
Issue number4
Publication statusPublished - 1 Apr 2018


  • AIDS Vaccines/administration & dosage
  • Animals
  • Antibodies, Neutralizing/blood
  • Clinical Trials as Topic
  • Drug Evaluation, Preclinical
  • HIV Antibodies/blood
  • HIV Infections/prevention & control
  • HIV-1/genetics
  • Host-Pathogen Interactions/immunology
  • Humans
  • Immunogenicity, Vaccine
  • Outcome Assessment, Health Care
  • Structure-Activity Relationship
  • Vaccination
  • Viral Proteins/chemistry


Dive into the research topics of 'Advances in HIV-1 Vaccine Development'. Together they form a unique fingerprint.

Cite this